Related Experiment Video
Updated: Aug 8, 2026

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery
V Aerra1, M Kuduvalli, A N Moloto
1Department of Cardiothoracic Surgery, The Cardiothoracic Centre Liverpool, UK. vikram.aerra@gmail.com
Journal of Cardiothoracic Surgery
|May 26, 2006
Summary
Sotalol and magnesium significantly reduce the incidence of post-operative atrial fibrillation in coronary surgery patients. This combination therapy offers a promising strategy for improving outcomes after cardiac procedures.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Post-operative atrial fibrillation (POAF) is a common complication following coronary surgery, affecting up to 40% of patients.
- POAF can lead to increased morbidity, mortality, and healthcare costs.
Purpose of the Study:
- To evaluate the efficacy of a combination therapy with sotalol and magnesium in reducing the incidence of POAF after coronary surgery.
Main Methods:
- A retrospective analysis of 103 coronary surgery patients was conducted.
- Patients received either sotalol and magnesium or no treatment (control group).
- Propensity score matching was used to create comparable groups of 89 patients each.
Main Results:
- The incidence of atrial fibrillation was significantly lower in the sotalol and magnesium group (13.5%) compared to the control group (27.0%) (p = 0.025).
- No significant difference in in-hospital mortality was observed between the groups.
Conclusions:
- The combination of sotalol and magnesium is effective in significantly reducing the incidence of post-operative atrial fibrillation after coronary surgery.
- This therapeutic approach may improve patient outcomes following cardiac procedures.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
